• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病1型:临床表现及诊断标准

Neurofibromatosis 1: clinical manifestations and diagnostic criteria.

作者信息

Friedman J M

机构信息

Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

出版信息

J Child Neurol. 2002 Aug;17(8):548-54; discussion 571-2, 646-51. doi: 10.1177/088307380201700802.

DOI:10.1177/088307380201700802
PMID:12403552
Abstract

Neurofibromatosis 1 occurs in 2 to 3 people per 10,000. The most frequent clinical features are café-au-lait macules, neurofibromas, intertriginous freckling, Lisch nodules, and learning disabilities, but optic and other gliomas, malignant peripheral nerve sheath tumors, and characteristic osseous lesions also can be present. Two striking aspects of neurofibromatosis 1 are its progressive nature and its extreme variability. This article reviews the natural history and some important clinical manifestations of neurofibromatosis 1, with emphasis on features that constitute the standard diagnostic criteria. The pathogenic implications of these clinical manifestations are also considered.

摘要

神经纤维瘤病1型的发病率为每10000人中2至3人。最常见的临床特征是咖啡斑、神经纤维瘤、间擦部位雀斑、虹膜错构瘤和学习障碍,但也可能出现视神经及其他胶质瘤、恶性外周神经鞘瘤和特征性骨病变。神经纤维瘤病1型的两个显著特点是其进行性本质和极大的变异性。本文回顾了神经纤维瘤病1型的自然病史和一些重要的临床表现,重点关注构成标准诊断标准的特征。还考虑了这些临床表现的致病意义。

相似文献

1
Neurofibromatosis 1: clinical manifestations and diagnostic criteria.神经纤维瘤病1型:临床表现及诊断标准
J Child Neurol. 2002 Aug;17(8):548-54; discussion 571-2, 646-51. doi: 10.1177/088307380201700802.
2
Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.1型神经纤维瘤病样综合征的临床和突变谱
JAMA. 2009 Nov 18;302(19):2111-8. doi: 10.1001/jama.2009.1663.
3
Phakomatoses.斑痣病。
Dermatol Clin. 2019 Oct;37(4):583-606. doi: 10.1016/j.det.2019.05.015.
4
Neurofibromatosis type I: genetics and clinical manifestations.I型神经纤维瘤病:遗传学与临床表现
Semin Ophthalmol. 2008 Jan-Feb;23(1):45-51. doi: 10.1080/08820530701745223.
5
Neurofibromas in children with neurofibromatosis 1.1型神经纤维瘤病患儿的神经纤维瘤
J Child Neurol. 2002 Aug;17(8):585-91; discussion 602-4, 646-51. doi: 10.1177/088307380201700808.
6
[Neurofibromatosis type 1 or Von Recklinghausen's disease].1型神经纤维瘤病或冯·雷克林豪森病
Rev Med Interne. 2005 Mar;26(3):196-215. doi: 10.1016/j.revmed.2004.06.011.
7
A clinical study of type 1 neurofibromatosis in north west England.英格兰西北部1型神经纤维瘤病的临床研究。
J Med Genet. 1999 Mar;36(3):197-203.
8
Neurofibromatosis type 1.1型神经纤维瘤病
Handb Clin Neurol. 2015;132:75-86. doi: 10.1016/B978-0-444-62702-5.00004-4.
9
Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?1型神经纤维瘤病的非典型血液学和肾脏表现:巧合还是病理生理联系?
Eur J Med Genet. 2014 Nov-Dec;57(11-12):639-42. doi: 10.1016/j.ejmg.2014.09.001. Epub 2014 Sep 16.
10
Clinical and genetic aspects of neurofibromatosis 1.神经纤维瘤病 1 的临床和遗传方面。
Genet Med. 2010 Jan;12(1):1-11. doi: 10.1097/GIM.0b013e3181bf15e3.

引用本文的文献

1
Lifelong Management of Neurofibromatosis 1 Patients.神经纤维瘤病1型患者的终身管理
J Korean Neurosurg Soc. 2025 May;68(3):261-271. doi: 10.3340/jkns.2025.0057. Epub 2025 Apr 16.
2
Examining Demographic and Clinical Traits in Neurofibromatosis Type 1 Patients: Insights into Vitamin D Levels and Connections with Nevus Anemicus and Neurofibromas.研究1型神经纤维瘤病患者的人口统计学和临床特征:对维生素D水平以及与贫血痣和神经纤维瘤关联的见解。
Indian J Dermatol. 2025 Jan-Feb;70(1):11-17. doi: 10.4103/ijd.ijd_141_24. Epub 2024 Dec 30.
3
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.
一项关于1型神经纤维瘤病(NF1)成人患者在司美替尼临床试验中药物依从性的混合方法研究。
Cancers (Basel). 2025 Jan 17;17(2):295. doi: 10.3390/cancers17020295.
4
Analysis of visual evoked potentials in patients with neurofibromatosis type 1: new concepts.1型神经纤维瘤病患者视觉诱发电位分析:新概念
Front Neurol. 2024 Jul 22;15:1410101. doi: 10.3389/fneur.2024.1410101. eCollection 2024.
5
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.当代神经纤维瘤病 1 型相关恶性外周神经鞘瘤治疗方法。
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e432242. doi: 10.1200/EDBK_432242.
6
Mutation Associated with Depigmented Patches Regression and Multiple Café-au-lait Macules Development in a Patient with Piebaldism: A Case Report.斑驳病患者色素脱失斑消退与多发咖啡斑形成相关的突变:一例报告
Clin Cosmet Investig Dermatol. 2024 Mar 20;17:713-716. doi: 10.2147/CCID.S449691. eCollection 2024.
7
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.开发并初步验证了一种用于 1 型神经纤维瘤病患儿丛状神经纤维瘤毁容严重程度的新型量表。
Clin Trials. 2024 Apr;21(2):189-198. doi: 10.1177/17407745231206402. Epub 2023 Oct 25.
8
Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas.围产期叶酸水平并不影响 NF1 相关丛状神经纤维瘤模型中的肿瘤潜伏期或多发性。
BMC Res Notes. 2023 Oct 17;16(1):275. doi: 10.1186/s13104-023-06515-8.
9
Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene.NF1 基因新致病性变异导致的极度广泛节段性丛状神经纤维瘤的镶嵌现象。
Int J Mol Sci. 2023 Jul 29;24(15):12154. doi: 10.3390/ijms241512154.
10
Olfactory groove monophasic sinovial sarcoma and von Recklinghausen's disease: A case report and literature review.嗅沟单相性滑膜肉瘤与冯雷克林霍增氏病:一例报告及文献复习
Surg Neurol Int. 2023 Jul 7;14:231. doi: 10.25259/SNI_338_2023. eCollection 2023.